Shire Buys Swedish Infant Blindness Researcher

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

Dublin, Ireland-based branded pharmaceuticals firm Shire (NASDAQ: SHPG  ) has bought privately owned Swedish biotech Premacure for an undisclosed sum, as Shire confirmed Tuesday.

Premacure currently has a protein replacement therapy in phase 2 development, aimed at preventing a rare and potentially blinding eye disorder that can affect premature infants, known as retinopathy of prematurity (ROP). According to Shire, ROP afflicts as many as 14,000 to 16,000 preterm infants in the U.S. annually, with just under 10% of these patients requiring medical treatment.

Shire will pay an unspecified sum up front for Premacure, followed by later milestone payments as Premacure's treatment progresses toward commercial sale. In acquiring Premacure, Shire says it's entering a new therapeutic area -- neonatology -- and the company intends to continue Premacure's work, adding the company's new "investigational protein" to its pipeline of other drugs in development.

Investors reacted to news of the acquisition by bidding Shire shares up 0.2%. Shares closed at $91.56 Tuesday.

Read/Post Comments (0) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2309141, ~/Articles/ArticleHandler.aspx, 9/29/2016 1:40:51 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 18,171.80 -167.44 -0.91%
S&P 500 2,153.69 -17.68 -0.81%
NASD 5,278.85 -39.70 -0.75%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/29/2016 1:25 PM
SHPG $194.88 Down -4.69 -2.35%
Shire CAPS Rating: ****